Association of metabolic health and obesity with coronary heart disease in adult cancer survivors

Kyuwoong Kim,Edvige Di Giovanna,Hyeyun Jung,Lakshimi Deepak Bethineedi,Tae Joon Jun,Young‐Hak Kim
DOI: https://doi.org/10.1111/eci.14161
2024-01-20
European Journal of Clinical Investigation
Abstract:This study used data on 173,951 adult cancer survivors from the National Health Insurance Service database. During a follow‐up of more than 1.3 million person‐years, metabolically healthy obese individuals had a 52% higher risk of coronary heart disease (CHD) as compared to those without obesity and metabolic abnormalities. Metabolically unhealthy nonobese and metabolically unhealthy obese phenotypes were also significantly associated with an increased risk of CHD. Our findings underline the importance of managing obesity and metabolic health in cancer survivorship. Background The metabolically healthy obese (MHO) phenotype is associated with an increased risk of coronary heart disease (CHD) in the general population. However, association of metabolic health and obesity phenotypes with CHD risk in adult cancer survivors remains unclear. We aimed to investigate the associations between different metabolic health and obesity phenotypes with incident CHD in adult cancer survivors. Methods We used National Health Insurance Service (NHIS) to identify a cohort of 173,951 adult cancer survivors aged more than 20 years free of cardiovascular complications. Metabolically healthy nonobese (MHN), MHO, metabolically unhealthy nonobese (MUN), metabolically unhealthy obese (MUO) phenotypes were created using as at least three out of five metabolic health criteria along with obesity (body mass index ≥ 25.0 kg/m2). We used Cox proportional hazards model to assess CHD risk in each metabolic health and obesity phenotypes. Results During 1,376,050 person‐years of follow‐up, adult cancer survivors with MHO phenotype had a significantly higher risk of CHD (hazard ratio [HR] = 1.52; 95% confidence intervals [CI]: 1.41 to 1.65) as compared to those without obesity and metabolic abnormalities. MUN (HR = 1.81; 95% CI: 1.59 to 2.06) and MUO (HR = 1.92; 95% CI: 1.72 to 2.15) phenotypes were also associated with an increased risk of CHD among adult cancer survivors. Conclusions Adult cancer survivors with MHO phenotype had a higher risk of CHD than those who are MHN. Metabolic health status and obesity were jointly associated with CHD risk in adult cancer survivors.
medicine, general & internal, research & experimental
What problem does this paper attempt to address?